Aura Biosciences (AURA) Operating Expenses (2020 - 2026)
Aura Biosciences' (AURA) quarterly Operating Expenses came in at $34.9 million in Q1 2026, up 20.08% YoY from $29.0 million in Q1 2025, and up 28.01% on a QoQ basis from $27.2 million in Q4 2025.
Aura Biosciences (AURA) Operating Expenses (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Operating Expenses data on file, last reported at $34.9 million in Q1 2026.
- Quarterly Operating Expenses rose 20.08% year-over-year to $34.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.6 million (up 15.35% YoY) and the FY2025 annual result came in at $112.8 million, up 17.35% from the prior year.
- Operating Expenses rose to $34.9 million in Q1 2026, from $27.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $34.9 million in Q1 2026 to a low of $12.8 million in Q1 2022.
- A 5-year average of $22.9 million and a median of $22.8 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 174.88% — and 2025, when it declined 2.05%.
- Tracing AURA's Operating Expenses over 5 years: stood at $17.6 million in 2022, then jumped by 40.71% to $24.8 million in 2023, then climbed by 12.2% to $27.8 million in 2024, then slipped by 2.05% to $27.2 million in 2025, then grew by 28.01% to $34.9 million in 2026.
- The last three Operating Expenses figures came in at $34.9 million (Q1 2026), $27.2 million (Q4 2025), and $27.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | 48.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.07 Mn |
| Mar 31, 2026 | 34.87 Mn |
| Dec 31, 2025 | 27.24 Mn |
| Sep 30, 2025 | 27.91 Mn |
| Jun 30, 2025 | 28.61 Mn |
| Mar 31, 2025 | 29.04 Mn |
| Dec 31, 2024 | 27.81 Mn |
| Sep 30, 2024 | 23.23 Mn |
| Jun 30, 2024 | 22.76 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Dec 31, 2023 | 24.78 Mn |
| Sep 30, 2023 | 20.49 Mn |
| Jun 30, 2023 | 20.28 Mn |
| Mar 31, 2023 | 19.44 Mn |
| Dec 31, 2022 | 17.61 Mn |
| Sep 30, 2022 | 16.06 Mn |
| Jun 30, 2022 | 13.82 Mn |
| Mar 31, 2022 | 12.81 Mn |
| Dec 31, 2021 | -23.52 Mn |
| Sep 30, 2021 | 8.90 Mn |